Ng, T., Berz, D., Birnbaum, A., Dipetrillo, T. A., Henderson, D., Kennedy, T., & Ready, N. E. (2008). Neoadjuvant carboplatin and weekly paclitaxel for stage Ib-IIIa non-small cell lung cancer (NSCLC): A Brown University Oncology Group (BrUOG) phase II study. In Journal of Clinical Oncology (Vol. 26, pp. 18502–18502). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2008.26.15_suppl.18502

Ng, T., D. Berz, A. Birnbaum, T. A. Dipetrillo, D. Henderson, T. Kennedy, and N. E. Ready. “Neoadjuvant carboplatin and weekly paclitaxel for stage Ib-IIIa non-small cell lung cancer (NSCLC): A Brown University Oncology Group (BrUOG) phase II study.” In Journal of Clinical Oncology, 26:18502–18502. American Society of Clinical Oncology (ASCO), 2008. https://doi.org/10.1200/jco.2008.26.15_suppl.18502.

Ng T, Berz D, Birnbaum A, Dipetrillo TA, Henderson D, Kennedy T, et al. Neoadjuvant carboplatin and weekly paclitaxel for stage Ib-IIIa non-small cell lung cancer (NSCLC): A Brown University Oncology Group (BrUOG) phase II study. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2008. p. 18502–18502.

Ng, T., et al. “Neoadjuvant carboplatin and weekly paclitaxel for stage Ib-IIIa non-small cell lung cancer (NSCLC): A Brown University Oncology Group (BrUOG) phase II study.” Journal of Clinical Oncology, vol. 26, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2008, pp. 18502–18502. Crossref, doi:10.1200/jco.2008.26.15_suppl.18502.

Ng T, Berz D, Birnbaum A, Dipetrillo TA, Henderson D, Kennedy T, Ready NE. Neoadjuvant carboplatin and weekly paclitaxel for stage Ib-IIIa non-small cell lung cancer (NSCLC): A Brown University Oncology Group (BrUOG) phase II study. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2008. p. 18502–18502.